End-to-end platform tailored for the hospital’s vascular care team helps detect suspected vascular disease and improve patient outcomes
Delray Beach, FL – December 14, 2022— As a leader in vascular care, Delray Medical Center is the first hospital in Florida to acquire the Viz Vascular Suite. This is a comprehensive software its vascular care team can use to detect disease, optimize workflow, and coordinate care. The Viz Vascular Suite uses artificial intelligence (AI) to automatically detect suspected pulmonary embolism, right/left ventricle dilation, aortic dissection, and abdominal aortic aneurysm to facilitate informed and efficient treatment decisions.
“Being able to identify a patient with a serious vascular condition, such as an abdominal aortic aneurysm, early – before they have an emergency, is a game changer and literally a lifesaver,” said Dr. Joseph Ricotta, professor of surgery and program director of the vascular surgery fellowship at Florida Atlantic University College of Medicine, and national medical director of vascular surgery and endovascular therapy at Tenet Healthcare. “For example, there are roughly 1.5 million abdominal aortic aneurysms in the US per year; however, only 10 percent get diagnosed and treated. We don’t often find out about them until it’s too late and, even then, there’s only a 25 percent chance of living through a ruptured aortic aneurysm. From my experience as an early adopter of this technology, the Viz Vascular Suite will help enhance screening and coordinate care across my vascular team.”
The Viz Vascular Suite is designed to automatically analyze imaging and data and, in turn, eliminate futile patient transfers between departments and decrease the time patients spend in the emergency department. Using the Viz.ai platform, care can be coordinated for any vascular pathology, and managed remotely within a hub and spoke network, which expedites diagnosis and treatment. It also aids Delray Medical Center in activating its Pulmonary Embolism Response Team (PERT), which is a multidisciplinary team that rapidly assesses and provides treatment for patients with acute pulmonary embolism.
“We set out to build a solution where any patient with life-threatening, vascular diseases can benefit from AI-powered triage, fast mobile communication and synchronized care coordination,” said Gad Sakin, chief product officer at Viz.ai. “The Viz Vascular Suite is designed to bring the advantages of intelligent care coordination to even more patients and help clinical teams, like the one at Delray Medical Center, achieve better clinical outcomes.”
In addition to the latest acquisition of the Viz Vascular Suite, Delray Medical Center is utilizing the technology for an investigational study using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 system in the treatment of acute pulmonary embolism. The purpose of this study is to evaluate the safety and effectiveness of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE in a prospective trial of patients with acute intermediate-risk pulmonary embolism.
Remaining on the forefront of new technology and treatments has been a hallmark of the vascular program at Delray Medical Center as it was the first in the country to perform endovascular robotic surgery, the first in Florida to perform trans-carotid revascularization (TCAR) for the treatment of carotid artery disease and stroke, the first in Florida to perform Venaseal TM for the treatment of venous disease, and the first in Palm Beach county to perform intravascular lithotripsy balloon angioplasty for peripheral vascular disease. Rounding out Delray Medical Center’s endovascular program are a Limb Preservation Program, a new Hybrid Endovascular OR Suite, the CorPath system for robotic-assisted vascular interventions, and the Artis pheno, which is a robotic C-arm angiography system for use in minimally invasive interventional procedures that improves flexibility in the OR by expanding patient access, reducing radiation and maintaining an uninterrupted sterile airflow with antimicrobial surfaces. Equipped with advanced, robotic surgical technology not available at any other hospital in Palm Beach County, the experienced team of physicians and surgeons at Delray Medical Center offer even more minimally invasive vascular interventional procedures to patients, including specialized procedures that are designed to spare tissue, repair damage and help maintain and restore function in limbs that would otherwise have to be amputated.
Other conditions treated include:
- Aortic Aneurysm
- Carotid Artery Disease
- Deep Vein Thrombosis/Pulmonary Embolism
- Diabetic Peripheral Neuropathy
- Diabetic Ulcers/Wounds
- Mesenteric and Renal Disease
- Pelvic Congestion Syndrome and Thoracic Outlet Syndrome
- Peripheral Vascular Disease/Peripheral Arterial Disease
- Vascular Malformations
- Venous Disease
- Dialysis Access
For more information about the Endovascular Program at Delray Medical Center, log on to Endovascular Robotics Surgery Delray Beach, FL | Delray Medical Center (delraymedicalctr.com) or call 1-833-769-4862 for a free physician referral.
About Delray Medical Center
For nearly 40 years, Delray Medical Center, part of the Palm Beach Health Network, is a 536-bed acute care hospital, has served the communities of South Palm Beach County. As both a community hospital and state-designated Level I Trauma Center located on a 42-acre medical plaza, Delray Medical Center has the ability to offer several specialized services including cardiac care, orthopedics, rehabilitation, neurosciences, emergency care, and more.
Delray Medical Center is a recipient of the Healthgrades Patient Safety Excellence Award for four years in a row, a designation recognizing superior performance of hospitals preventing the occurrence of serious, potentially avoidable complications for patients during hospital stays. The hospital is also a Five-Star Recipient for Treatment of Heart Failure for 19 years in a row (2003-2022).
Delray Medical Center is a state-designated Comprehensive Stroke Center and received Get With The Guidelines award for advanced therapy for Thrombectomy. In addition, the hospital earned the Get With the Guidelines – American Heart/Stroke Association’s Gold Plus, Target Stroke Elite Plus, Target Stroke Advanced Therapy, and TT2 Diabetes Honor Roll Get With The Guidelines® – Stroke quality achievement awards in 2022. Delray Medical Center was also named by Healthgrades as a Five-Star Recipient for Treatment of Stroke for 14 years in a row (2008-2022). Pinecrest Rehabilitation and Outpatient Hospital at Delray Medical Center is a CARF accredited rehabilitation unit, and the only state designated brain and spinal cord injury rehabilitation program in Palm Beach County by the state of Florida, Department of Health. Delray Medical Center is also recognized as a high performing hospital in 2022, for the treatment of COPD by U.S. News and World Report. The hospital is also a Bariatric Surgery Center of Excellence. For more information about our services, visit our website at www.delraymedicalctr.com.
About Viz.ai, Inc.
Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,200+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.
 Viz AAA is 510(k) pending. Not available for sale.